Tag: black box warning
Noted antidepressant researcher, Michael Hengartner, summarizes the latest research on the use of antidepressants in children and adolescents.
Researchers confirm that the suicide warning for antidepressants is justified by the evidence and that claims that the warning is harmful lack support.
STAT recently published an opinion piece arguing that the black box warning on antidepressants has led to an increase in adolescent suicide. It is easily debunked, and reveals once again how our society is regularly misled about research findings related to psychiatric drugs. STAT has lent its good name to a false story that, unfortunately, will resonate loudly with the public.
The National Coalition for Mental Health Recovery is calling upon all people of like minds, who care about individuals who need mental health services, to ACT. It is urgent. Please call your representative in the House of Representatives to vigorously oppose HR 2646 on Tuesday, July 5, 2016. And, call your Senator to insist that the Senate reject any amendments or changes to mental health legislation from the House by Friday, July 8, 2016. For more information about this Call to Action, please click here.
As you read this, people with lived experience all around the country are mobilizing to educate our federal legislators about why the Helping Families in Mental Health Crisis Act (H.R. 2646) should be defeated. Education is the key. As executive director of the National Coalition for Mental Health Recovery, I am issuing a call to action. We need to ramp up our efforts before this backward piece of legislation becomes law. We need to get in touch with our legislators and their staffs, contact the media, make some noise! We need to exercise the proverbial strength in numbers. And we need all of this now!
This month the candidates for President compete in our State of Oregon, so this is a very good time to ask the following question: “How do you stand on the controversy of forced outpatient mental health drugs?” This is my 40th year working as an advocate for people labeled “disabled,” and I know that the topic of involuntary psychiatry can be a little complicated for people. After all, if one of our beloved family members becomes irrationally self-destructive, we can become desperate for help. However, this is such an important topic that we need to go deeper than just a bumper-sticker answer.
Risperdal is increasingly used in nursing homes for “agitation,” especially on those suffering from some form of dementia, even when no hallucinations or delusions are observed. Risperdal has quite a long list of side effects including heart problems, metabolic difficulties, diabetes, involuntary movements, agitation, flat affect and sedation. Risperdal has earned a “black box" warning that its use in those with Alzheimer's increases the risk of earlier death. Yet its use in Alzheimer's patients in nursing homes is extremely common.
A former Duke University psychiatry chair is calling for a retraction of a study suggesting that the FDA's black-box warnings about increased suicidality in youth taking SSRIs led to increases in adolescent suicide attempts.
A British Medical Journal study led by Harvard Medical School's Christine Lu suggested that black box warnings about increased suicidality in youth who take antidepressants actually led to increases in adolescent suicide attempts. However, the latest in a stream of critics of that conclusion are the authors of one of the key studies cited by Lu in support of her team's analysis.
A study that appeared online in the British Medical Journal suggests that the FDA’s warning in 2003 that antidepressants increase the risk of suicidal ideation in youth paradoxically led to an increase in suicide attempts in this age group. Media reports on the study tell of how the black-box warning “backfired.” But is this conclusion warranted by the study? Or is the study flawed? And how did the media report on this story?